Site-Overview.com
 

18 websites are associated with address One Amgen Center Drive

 
Websites found: 18
Number of websited displayed: 18
 

List of results:

Enbrel® (etanercept)
http://site-overview.com/stats/enbrel.com
Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe plaque psoriasis and rheumatoid arthritis.
  • Google Analytics ID: 70400828-1
  • Website Address renewal date: 17/1/10
  • Domain Address Reg. date: 99/2/11
  • Website address in use until: 18/2/11
Amgen
http://site-overview.com/stats/onyx.com
  • Google Analytics ID: 22843556-1
  • Website Address renewal date: 16/7/5
  • Domain Address Reg. date: 97/8/7
  • Website address in use until: 17/8/6
Amgen Italia
http://site-overview.com/stats/amgen.it
  • Google Analytics ID: 109443116-1
  • Website Address renewal date: 17/6/23
  • Domain Address Reg. date: 98/11/6
  • Website address in use until: 18/6/7
Amgen
http://site-overview.com/stats/amgen.com
  • Google Analytics ID: 22843556-1
  • Website Address renewal date: 15/9/17
  • Domain Address Reg. date: 90/7/27
  • Website address in use until: 23/7/26
BiTE® Immunotherapy: Official site
http://site-overview.com/stats/biteantibodies.com
Learn how investigational BiTE® antibodies can activate endogenous T cells to target malignant cells. Watch the proposed mechanism of BiTE® video.
  • Website Address renewal date: 16/9/28
  • Domain Address Reg. date: 13/10/30
  • Website address in use until: 17/10/30
High Cholesterol Treatment | Lower LDL | Repatha® (evolocumab)
http://site-overview.com/stats/repatha.com
Repatha® (evolocumab) is used along with diet & maximally tolerated statin for high LDL cholesterol.
  • Website Address renewal date: 16/10/21
  • Domain Address Reg. date: 13/11/22
  • Website address in use until: 17/11/22
Neulasta® (pegfilgrastim) | G-CSF Injection
http://site-overview.com/stats/neulasta.com
Learn about Neulasta® (pegfilgrastim) and Neulasta® Onpro™, the on-body injector designed to administer Neulasta®.
  • Website Address renewal date: 16/12/10
  • Domain Address Reg. date: 02/1/11
  • Website address in use until: 18/1/11
IMLYGIC® (talimogene laherparepvec) Oncolytic Viral Therapy
http://site-overview.com/stats/imlygic.com
Find information about IMLYGIC® (talimogene laherparepvec), including details about administration, storage, safety information and more.
  • Website Address renewal date: 17/2/25
  • Domain Address Reg. date: 12/3/29
  • Website address in use until: 18/3/29
Amgen Scholars
http://site-overview.com/stats/amgenscholars.com
The Amgen Scholars Program provides hundreds of selected undergraduates with the opportunity to engage in a hands-on research experience at many of the world’s leading institutions.
  • Google Analytics ID: 27399718-1
  • Website Address renewal date: 17/4/24
  • Domain Address Reg. date: 06/5/26
  • Website address in use until: 18/5/26
amgentrials.com
http://site-overview.com/stats/amgentrials.com
  • Website Address renewal date: 17/3/8
  • Domain Address Reg. date: 99/4/9
  • Website address in use until: 18/4/9
For the Treatment of Postmenopausal Osteoporosis Women at High Risk for Fracture | Prolia® (denosumab)
http://site-overview.com/stats/prolia.com
Learn how Prolia® (denosumab) can help in the treatment of postmenopausal osteoporosis for women at high risk for fracture.
  • Website Address renewal date: 16/8/7
  • Domain Address Reg. date: 99/9/8
  • Website address in use until: 17/9/8
KYPROLIS® (carfilzomib) for Relapsed Multiple Myeloma Treatment
http://site-overview.com/stats/kyprolis.com
KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. Learn how KYPROLIS may help.
  • Website Address renewal date: 15/11/10
  • Domain Address Reg. date: 10/5/11
  • Website address in use until: 17/5/11
aranesp.com
http://site-overview.com/stats/aranesp.com
  • Website Address renewal date: 16/8/12
  • Domain Address Reg. date: 99/9/13
  • Website address in use until: 17/9/13
www.amgenbiosimilars.com
http://site-overview.com/stats/amgenbiosimilars.com
Biosimilars Scientific Complexities and Emerging Opportunities
  • Website Address renewal date: 16/10/5
  • Domain Address Reg. date: 12/11/6
  • Website address in use until: 17/11/6
ITP Treatment - ITP (immune thrombocytopenia) & Nplate® (romiplostim)
http://site-overview.com/stats/nplate.com
Nplate® (romiplostim) - The Official Site - Learn more about ITP (immune thrombocytopenia) and Nplate®, a treatment for adults with chronic ITP.
  • Website Address renewal date: 16/12/11
  • Domain Address Reg. date: 08/1/12
  • Website address in use until: 18/1/12
EPOGEN® treatment for patients with anemia due to chronic kidney disease (CKD) | EPOGEN® (epoetin alfa)
http://site-overview.com/stats/epogen.com
EPOGEN® (epoetin alfa) is used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis to reduce or avoid the need for red blood cell transfusions.
  • Website Address renewal date: 17/4/25
  • Domain Address Reg. date: 98/5/28
  • Website address in use until: 18/5/27
Chemotherapy.com | Chemotherapy Information and Education for Cancer Patients and Caregivers
http://site-overview.com/stats/chemotherapy.com
  • Website Address renewal date: 16/5/24
  • Domain Address Reg. date: 97/6/26
  • Website address in use until: 17/6/25
Patients with Bone Metastases from Solid Tumors | XGEVA® (denosumab)
http://site-overview.com/stats/xgeva.com
Learn more about preventing serious bone problems with XGEVA® (denosumab) injections.
  • Website Address renewal date: 16/5/6
  • Domain Address Reg. date: 10/6/7
  • Website address in use until: 17/6/7
2024-05-05 12:06:50 ... 0.0135